Fluorodeoxyglucose uptake in dysfunctional myocardium subtended by an occluded coronary artery: Relation to dobutamine contractile reserve and Sestamibi uptake

International Journal of Cardiac Imaging

Volumn 14, Issue 2, 1998, Pages 97-104

  Kofoed, Klaus F ^a   Carstensen, Steen ^a   Hesse, Birger ^a   Hove, Jens D ^a   Holm, Søren ^a   Jensen, Mikael ^a   Haunsø, Stig ^a   Kelbæk, Henning ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dobutamine echocardiography; Myocardial viability; PET; SPECT

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; MYOCARDIAL DISEASE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; CARDIOTONIC AGENTS; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031980923     PISSN: 01679899     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005913113840     Document Type: Article

References (38)

1. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for 'hibernating myocardium'. J Am Coll Cardiol 1986; 8: 1467-1470.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
3. Jain D, Zaret BL. Nuclear imaging techniques for the assessment of myocardial viability. Cardiol Clin 1995; 13: 43-57.
4. Di Carli M, Davidson M, Little R, Khanna S, Brunken R, Czernin J, Rokhsar S, Stevenson L, Laks H, Hawkins R, Schelbert HR, Phelps ME. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
5. Eitzman D, Al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb MG, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. JACC 1992; 20: 559-65.
6. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132-9.
7. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982; 23: 577-586.
8. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert HR. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. New Engl J Med 1986; 314: 884-888.
9. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-865.
10. vom-Dahl J, Altehoefer C, Sheehan F, Buechin P, Uebis R, Messmer B, Buell U, Hanrath P. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability by nuclear imaging and vessel patency at follow-up angiography. JACC 1996; 28: 948-58.
11. Arnese M, Cornel JH, Salustri A, Maat A, Elhendy A, Reijs AE, Ten-Cate FJ, Keane D, Balk AH, Roelandt JR, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995; 91: 2748-52.
12. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995; 91: 990-8.
13. deFilippi C, Willett D, Irani W, Eichhorn E, Velasco C, Grayburn P. Comparison of myocardial contrast chocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995; 92: 2863-2868.
14. Baer FM, Smolarz K, Theissen P, Voth E, Schicha H, Sechtem U. Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J 1994; 15: 97-107.
15. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994; 89: 2552-61.
16. Sawada SG, Allman KC, Muzik O, Beanlands RS, Wolfe E, Jr., Gross M, Fig L, Schwaiger M. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 23: 92-8.
17. Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995; 92: 994-1004.
18. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) Technetium in cultured chick myocardial cells. Circulation 1990; 82: 1826-1838.
19. Beanlands RSB, Dawood F, Wen W-H, McLaughlin PR, Butany J, D'Amati G, Liu PP. Are the kinetics of Technetium 99m methoxyisobutyl isonitrile affected by cell metabolism and viability. Circulation 1990; 82: 1802-1814.
20. Carstensen S, ALi S, Stensgaard-Hansen F, Toft J, Haunsoe S, Kelbaek H, Saunamaki K. Dobutamine-atropine stress echocardiography in asymptomatic normal individuals: the relativity of stress induced hyperkinesia. Circulation 1995; 92: 3453-3463.
21. De Fronzo RA, Jordan DT, Reubin A. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devreux R, Feigenbaum H. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
23. Knuuti MJ, Nuutila P, Ruotsalainen U, Teras M, Saraste M, Harkonen R, Ahonen A, Wegelius U, Haapanen A, Bergman J, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993; 34: 2068-75.
24. Metz C. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
25. Knuuti MJ, Saraste M, Nuutila P, Harkonen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994; 127: 785-96.
26. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium [see comments]. Circulation 1993; 87: 1513-23.
27. Liedtke AJ, Renstrom B, Nellis SH, Hall JL, Stanley WC. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol 1995; 26: 815-25.
28. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995; 76: 479-88.
29. Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996; 93: 737-744.
30. Depre C, Vanoverschelde JL, Melin JA, Borgers M, Bol A, Ausma J, Dion R, Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995; 268: H1265-75.
31. Altehoefer C, vom-Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F, Hanrath P, Buell U. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569-74.
32. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995; 75: 1214-9.
33. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation 1994; 89: 578-87.
34. Baer FM, Voth E, Deutsch HJ, Schneider CA, Schicha H, Sechtem U. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994; 24: 343-53.
35. Schelbert HR, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation 1988; 78: 496-505.
36. Kaul S. Response of dysfunctional myocardium to dobutamine. The eyes see what the mind knows! JACC 1996; 27: 1608-11.
37. Chen C, Li L, Chen LL, Prada JV, Chen MH, Fallen JT, Weyman AE, Waters D, Gillam L. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995; 92: 756-66.
38. Senior R, Raval U, Lahiri A. Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssynergic myocardial segments. J Nucl Cardiol 1995; 2: 296-302.